Renata Barbosa de Oliveira

Universidade Federal de Minas Gerais — Brazil

Chemistry · Physical Sciences

22h-index1.7kcitations113works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Synthesis and biological activity(23), Research on Leishmaniasis Studies(23), Synthesis and Biological Evaluation(21), Trypanosoma species research and implications(19), Computational Drug Discovery Methods(16)

Publications113 total

Diálogos e dissonâncias
Revista Semiárido De Visu·2025Open Access
Green Strategies for the Synthesis of Heterocyclic Derivatives with Potential Against Neglected Tropical Diseases
Reactions·2025Open Access
Green Synthetic Strategies in the Design of Bioactive Heterocycles for Neglected Tropical Disease Drug Discovery
Preprints.org·2025Open Access
Design of arylfurans as potential FAAH inhibitors: therapeutic potential in pain management
Bioorganic & Medicinal Chemistry·2025· 1 cited
Antifungal Efficacy of a Thiazolyl Hydrazone Derivative Incorporated into a Self-Emulsifying Drug Delivery System in a Murine Model of Cryptococcosis
ACS Omega·2025Open Access
Discovery of Arylfuran and Carbohydrate Derivatives from the BraCoLi Library as Potential Zika Virus NS3pro Inhibitors
Future Pharmacology·2025· 1 citedOpen Access
Thiazole Derivatives as Promising Candidates for Cryptococcosis Therapy
ACS Infectious Diseases·2025· 6 citedOpen Access
Novel 2-Thiazolylhydrazone with Druggable Properties for Antifungal Application
Journal of Fungi·2025Open Access
Novel 2-Thiazolylhydrazone with Druggable Properties for Antifungal Application
Preprints.org·2025Open Access
Investigation of the activity of 4-aminoquinolines as cysteine protease inhibitors with application in the treatment of Chagas disease
Memórias do Instituto Oswaldo Cruz·2025· 1 citedOpen Access
Fabrication of Free-Standing Porous BaTiO Thick Films by Indirect Selective Laser Sintering
Journal of Material Science and Technology Research·2024Open Access
Advances in the Search for SARS-CoV-2 Mpro and PLpro Inhibitors
Pathogens·2024· 10 citedOpen Access
New drug discovery strategies for the treatment of benznidazole-resistance in <i>Trypanosoma cruzi</i> , the causative agent of Chagas disease
Expert Opinion on Drug Discovery·2024· 18 cited
Synthesis and Cytotoxic Studies of Pyrrole and Pyrrolidine Derivatives in Human Tumor Cell Lines
ChemistrySelect·2024· 4 cited
Front Cover: Synthesis and Antiallodynic Activity of Cannabidiol Analogue on Peripheral Neuropathy in Mice (Chem. Biodiversity 4/2024)
Chemistry & Biodiversity·2024Open Access
Enhancing oral bioavailability of an antifungal thiazolylhydrazone derivative: Development and characterization of a self-emulsifying drug delivery system
International Journal of Pharmaceutics·2024· 6 cited
Machine Learning-Based Virtual Screening of Antibacterial Agents against Methicillin-Susceptible and Resistant <i>Staphylococcus aureus</i>
Journal of Chemical Information and Modeling·2024· 10 citedOpen Access
Synthesis and Antiallodynic Activity of Cannabidiol Analogue on Peripheral Neuropathy in Mice
Chemistry & Biodiversity·2024· 2 cited
Assessing the reaction to and efficacy of the Screener drug discovery and development board game as a pedagogical tool in postgraduate courses
Brazilian Journal of Medical and Biological Research·2024Open Access
An Overview on Computational Methods Targeting the Endocannabinoid System
Computer-aided drug discovery and design·2024
page 1 of 6Next →

Frequent Co-authors

Vinícius Gonçalves Maltarollo(12), Rafaela Salgado Ferreira(11), Elaine M. Souza‐Fagundes(9), Ricardo José Alves(9), Álvaro J. Romanha(8), Cleudiomar Inácio Lino(7), Susana Johann(7), Thales Kronenberger(7), Saulo Fehelberg Pinto Braga(6), Nívea Pereira de Sá(6), Carlos Leomar Zani(5), Policarpo Ademar Sales(5), Carlos A. Rosa(5), Jonas Pereira Ramos(4), Nayara Cristina Fonseca(4), Silvane Maria Fonseca Murta(4), Luan Carvalho Martins(4), Daniel Assis Santos(4), Eleftherios Mylonakis(4), Beth Burgwyn Fuchs(4)